Pre-conference workshop with a focus on drug development by Novo Repair Impact Fund:

‘What, when and how to nominate a candidate’

6th AMR Conference, 7-8 April 2022, virtual event

Moderator: Ursula Theuretzbacher, Founder, CEFAIA


  • Enza Di Modugno,  Global Head Infectious Disease and Immunology, Pharma Partnering, F. Hoffmann-La-Roche Ltd
  • Aleksander Danilovski, CSO & Senior Vice President Global R&D and Regulatory Affairs, Xellia Pharmaceuticals

Jointly organized by: